CN106854682A - A kind of method that parting is carried out using gene infected by influenza - Google Patents
A kind of method that parting is carried out using gene infected by influenza Download PDFInfo
- Publication number
- CN106854682A CN106854682A CN201611226906.0A CN201611226906A CN106854682A CN 106854682 A CN106854682 A CN 106854682A CN 201611226906 A CN201611226906 A CN 201611226906A CN 106854682 A CN106854682 A CN 106854682A
- Authority
- CN
- China
- Prior art keywords
- influenza
- parting
- carried out
- seq
- viral rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A kind of method that parting is carried out using gene infected by influenza disclosed by the invention, is comprised the following steps:Step S1, viral RNA are extracted;Step S2, by viral RNA reverse transcription be cDNA;Step S3, entered using specific primer performing PCR amplification;Step S4, recovery pcr amplification product;Step S5, the recovery product is sequenced;Step S6, known array in sequencing result and public database is compared, unknown virus are divided to corresponding classification.The nucleotide sequence of the specific primer such as SEQ ID NO:1 to SEQ ID NO:Shown in 8.The method of the present invention is compared with traditional method based on Serologic detection, and the nucleic acid detection method detection efficiency of PCR-based principle is higher, more rapid and convenient, will be played a great role in the infectious disease emergency that happens suddenly.
Description
Technical field
The invention belongs to biology field, more particularly, to a kind of side that parting is carried out using gene infected by influenza
Method.
Background technology
Influenza (influenza) is the Acute respiratory infectious disease caused by influenza virus, and infectiousness is stronger, clinically
Based on the symptom such as hyperpyrexia, weak, headache, Muscular stiffness, often periodically trigger worldwide popular or be very popular.Stream
Influenza Virus have three types:A type (A types) influenza infection mammal and birds;B-mode (Type B) influenza virus is only felt
The dye mankind, the generation of disease is generally gentle compared with Alphavirus;Third type (c-type) influenza virus only infects the mankind, can't cause tight
The disease of weight.From the point of view of infection scale, Flu-A often causes eruption and prevalence, even pandemics, occurs within about 2~3 years
Small popular 1 time, according to the 4 pandemicities analysis for having occurred in the world, generation in general 10~15 years is once very popular.It is B-mode
, in outburst or small prevalence, the third type is based on distributing for influenza.
The clinical symptoms of influenza are similar to common cold, but flu episode is rapid, and infectiousness is strong, and virus itself is to existing
The drug resistance of medicine constantly strengthens, and vaccine protective effect is limited, therefore the quick of pathogen makes a definite diagnosis prevention of disease and early stage
The influenza diagnostic criteria for treating the Ministry of Public Health's promulgation that is significant points out that antidiastole relies primarily on aetology, spy
Heteronuclear acid is checked and serum antibody is determined.But rely on the classics sides such as virus purification culture, serodiagnosis and antigen detection
Method wastes time and energy, it is difficult to adapt to during Epidemic outbreak of disease the need for quick diagnosis.And PCR detection method has, and sensitivity is high, specificity
Good the advantages of, it is widely used in pathogen detection, is one of effective ways of pathogen antidiastole generally acknowledged at present.Accurate mirror
Other influenza virus type, for monitoring influenza activity and fashion trend, and early warning is made in the variation of infected by influenza, for influenza
Prevention and control be significant, while there is certain directive significance in diagnosis and treatment process to clinical line doctor.
The content of the invention
The technical problems to be solved by the invention are to be carried for the existing above-mentioned deficiency of existing influenza virus detection
For a kind of method that parting is carried out using gene infected by influenza, the method can be sequenced to A type and B-mode by PCR and a generation
Influenza virus carries out Genotyping.
The technical problems to be solved by the invention can be solved by the following technical programs:
A kind of method that parting is carried out using gene infected by influenza, is comprised the following steps:
Step S1, viral RNA are extracted;
Step S2, by viral RNA reverse transcription be cDNA;
Step S3, entered using specific primer performing PCR amplification;
Step S4, recovery pcr amplification product;
Step S5, the recovery product is sequenced;
Step S6, known array in sequencing result and public database is compared, unknown virus are divided to correspondence
Classification.
In a preferred embodiment of the invention, the nucleotide sequence of the specific primer such as SEQ ID NO:1 to
SEQ ID NO:Shown in 8.
The method of the present invention is compared with traditional method based on Serologic detection, the detection of nucleic acids side of PCR-based principle
Method detection efficiency is higher, more rapid and convenient, will be played a great role in the infectious disease emergency that happens suddenly.
Brief description of the drawings
Fig. 1 is template-PCB products dosage schematic diagram of the present invention.
Fig. 2 is template of the present invention-copy number schematic diagram.
Fig. 3 and Fig. 4 is inventive samples type schematic diagram.
Specific embodiment
The present invention is described in further detail with reference to specific embodiments and the drawings.
1st, viral RNA is extracted
1.1st, virus stock solution used 500ul is added in the eppendorf pipes of 1.5ml, TRIzol 1ml are added, it is fully mixed
Even, room temperature places 10min, it is ensured that virus coat is fully cracked;
1.2nd, the chloroform of 200ul is added, centrifugation lid is covered tightly, (solution is fully emulsified, into milky white firmly to shake centrifuge tube
Shape, no phase separation phenomenon), room temperature places 10min, and (due to chloroform low boiling point, volatile, centrifuge tube may pop during vibration, small
The heart);
1.3rd, 12000g room temperatures centrifugation 15min, takes upper phase and moves into another pipe (never inhaling dynamic white interphase);
1.4th, 500ul isopropanols are added, centrifuge tube is gently overturned and is fully mixed liquid, room temperature places 10min;
1.5th, 4 DEG C, 10000g centrifugation 10min, centrifugation finishes visible ttom of pipe white precipitate, and as RNA is carefully sucked with rifle
All supernatants;
1.6th, the ethanol of 1ml 75% is added, allows RNA precipitate to hang, 4 DEG C, 7500g centrifugation 5min carefully suck institute with rifle
There is supernatant, 5min is dried in super-clean bench;
1.7th, appropriate DEPC treatment water is added.
1.8th, RT is in suggestion immediately.To preserve, can be frozen in -70 DEG C after previous step adds ethanol, one can be preserved
Year;Can only be preserved 1 month or so at -20 DEG C if adding after DEPC water.
2nd, it is cDNA by viral RNA reverse transcription
2.1 add following reactant mixture in the test tube of ice bath:
Template ribonucleic acid:Total serum IgE 1-3 μ g
Primer:Oligo(dT)(50uM) 1μl
dNTP Mix(10mmol/L) 1μl
The 2.2 plus μ l of RNase free dH2O to 10,65 DEG C of incubation 5min after mixing, rapid ice bath after terminating.
2.3 add following reactant mixture in the test tube of ice bath:
Plus after the μ of RNase free dH2O to 20 l are gently mixed.
2.4 42 DEG C of reactant mixture 30-60min.
2.5 heat 5min at 95 DEG C terminates reaction, and put carries out subsequent experimental or freezen protective on ice.
3rd, design of primers
This patent in order to improve detection efficiency, stromatin (M) gene and hemagglutinin (HA) gene according to influenza virus
And neuraminidase (NA) separately designs primer and expanded, these primers are closed by upper Shanghai's style Sen Nuo bio tech ltd
Into primer sequence is as follows:
4.PCR is expanded:Enter performing PCR amplification to viral cDNA, obtain genetic fragment to be measured
Amplification system and program are as follows:
Following component is added in 0.2ml centrifuge tubes:
Mixing is flicked, the drop on brief centrifugation collection tube wall to ttom of pipe, in the enterprising performing PCR reaction of PCR amplification instrument, reaction
Parameter is as follows:
After the completion of reaction, taking 3ulPCR products carries out 1% agarose gel electrophoresis detection.Confirm pcr amplified fragment.
5th, the recovery of PCR primer
PCR primer is reclaimed with AxyPrep DNA gels QIAquick Gel Extraction Kit, and concrete operations are carried out by kit specification, is walked
It is rapid as follows:
5.1 cut the Ago-Gel containing target DNA under uviol lamp is put into clean centrifuge tube, weighs weight.
5.2 add 3 Buffer DE-A of gel volume, are well mixed after 75 DEG C of heating until gel piece melts completely
Change.
5.3 plus 0.5 Buffer DE-B of Buffer DE-A volumes, is well mixed;When separate DNA fragmentation is less than
During 400bp, 1 isopropanol of gel volume is added.
5.4 by mixed liquor, is transferred to DNA and prepares pipe 12,000 × g centrifugations 1min.Abandon filtrate.
5.5 will prepare pipe puts back into 2ml centrifuge tubes, plus 500 μ l Buffer W1,12,000 × g centrifugation 30s, abandons filtrate.
5.6 will prepare pipe puts back into 2ml centrifuge tubes, plus 700 μ l Buffer W2,12,000 × g centrifugation 30s, abandons filtrate.With
Same method is again with 700 μ l Buffer W2,12,000 × g centrifugations 1min.
5.7 will prepare during pipe puts back into 2ml centrifuge tubes, 12,000 × g centrifugations 1min.
5.8 will prepare pipe is placed in the 1.5ml centrifuge tubes of cleaning (being provided in kit), is preparing film center plus 25-30 μ
L deionized waters, are stored at room temperature 1min.12,000 × g is centrifuged 1min eluted dnas.
6th, generation sequencing
Generation sequencing is carried out using the technology based on Sanger dideoxy chain terminations, sequenator used is ABI3730xl.
7th, sequence alignment, divides influenza virus type
The sequence for obtaining will be sequenced to compare in ncbi database, unknown virus are divided to corresponding classification.
Sequence table (SEQUENCE LISTING)
<110 > Zhou Youliang
Hu Chunling Wang Haitaos Chen Feng
Wang Chaohui
<120 > HCV gene typings chips and classifying method
<160> 8
<210> 1
<211> 20
<212> DNA
<213>Artificial sequence
<400> 1
GGTTGCTCYTTYTCTATCTT
<210> 2
<211> 19
<212> DNA
<213>Artificial sequence
<400> 2
TCATCATATCCCANGCCAT
<210> 3
<211> 26
<212> DNA
<213>Artificial sequence
<400> 3
TTTTTTTTTT-ACTAGGGACGGCAAAC
<210> 4
<211> 25
<212> DNA
<213>Artificial sequence
<400> 4
TTTTTTTTTT-AGAACAACGCCTCCC
<210> 5
<2 11> 26
<212> DNA
<213>Artificial sequence
<400> 5
TTTTTTTTTT-AGAACACCAGTAAGAG
<210> 6
<211> 25
<212> DNA
<213>Artificial sequence
<400> 6
TTTTTTTTTT-AGCTAGTCTAGGGTG
<210>7
<211> 27
<212> DNA
<213>Artificial sequence
<400> 7
TTTTTTTTTT-GTCTGGTCTAGAGCACA
<210> 8
<2 11> 24
<212> DNA
<213>Artificial sequence
<400> 8
TTTTTTTTTT-GGCTCTTACCTACG
Claims (2)
1. a kind of method that parting is carried out using gene infected by influenza, it is characterised in that comprise the following steps:
Step S1, viral RNA are extracted;
Step S2, by viral RNA reverse transcription be cDNA;
Step S3, entered using specific primer performing PCR amplification;
Step S4, recovery pcr amplification product;
Step S5, the recovery product is sequenced;
Step S6, known array in sequencing result and public database is compared, unknown virus are divided to corresponding class
Not.
2. a kind of method that parting is carried out using gene infected by influenza as claimed in claim 1, it is characterised in that the spy
The nucleotide sequence of specific primer such as SEQ ID NO:1 to SEQ ID NO:Shown in 8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611226906.0A CN106854682A (en) | 2016-12-27 | 2016-12-27 | A kind of method that parting is carried out using gene infected by influenza |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611226906.0A CN106854682A (en) | 2016-12-27 | 2016-12-27 | A kind of method that parting is carried out using gene infected by influenza |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106854682A true CN106854682A (en) | 2017-06-16 |
Family
ID=59125983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611226906.0A Pending CN106854682A (en) | 2016-12-27 | 2016-12-27 | A kind of method that parting is carried out using gene infected by influenza |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106854682A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102286644A (en) * | 2011-08-26 | 2011-12-21 | 李艳 | Kit for genotyping hepatitis C virus (HCV) |
CN102337351A (en) * | 2010-07-16 | 2012-02-01 | 中山大学达安基因股份有限公司 | Typing detection kit for influenza virus |
CN104498622A (en) * | 2014-11-24 | 2015-04-08 | 湖北新纵科病毒疾病工程技术有限公司 | Primers, probes, and method used for influenza virus typing |
CN104611423A (en) * | 2009-11-16 | 2015-05-13 | 基因特力株式会社 | Genotyping method |
KR20150134004A (en) * | 2014-05-21 | 2015-12-01 | 대한민국(농림축산식품부 농림축산검역본부장) | Nucleic acid test based avian influenza virus detection kit with improved detection accuracy |
-
2016
- 2016-12-27 CN CN201611226906.0A patent/CN106854682A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104611423A (en) * | 2009-11-16 | 2015-05-13 | 基因特力株式会社 | Genotyping method |
CN102337351A (en) * | 2010-07-16 | 2012-02-01 | 中山大学达安基因股份有限公司 | Typing detection kit for influenza virus |
CN102286644A (en) * | 2011-08-26 | 2011-12-21 | 李艳 | Kit for genotyping hepatitis C virus (HCV) |
KR20150134004A (en) * | 2014-05-21 | 2015-12-01 | 대한민국(농림축산식품부 농림축산검역본부장) | Nucleic acid test based avian influenza virus detection kit with improved detection accuracy |
CN104498622A (en) * | 2014-11-24 | 2015-04-08 | 湖北新纵科病毒疾病工程技术有限公司 | Primers, probes, and method used for influenza virus typing |
Non-Patent Citations (4)
Title |
---|
E. STARICK ET AL.,: ""Type- and Subtype-Specific RT-PCR Assays for Avian Influenza A Viruses (AIV)"", 《J.VET.MED.B》 * |
梁新乐: "《现代微生物学实验指导》", 31 March 2014, 浙江工商大学出版社 * |
王斗: ""常见流感病毒分型基因芯片检测方法的建立和应用"", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
薛文仲等: ""流感病毒的检测和分型技术研究进展"", 《生物技术通讯》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Molecular characterization of a bovine enteric calicivirus: relationship to the Norwalk-like viruses | |
Nasri et al. | Typing of human enterovirus by partial sequencing of VP2 | |
Zell et al. | Detection of porcine enteroviruses by nRT–PCR: differentiation of CPE groups I–III with specific primer sets | |
Naito et al. | Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease | |
Doan et al. | Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam | |
CN110184393A (en) | A kind of primer sets, purposes, kit and its detection method detecting African swine fever virus | |
CN109517927A (en) | A kind of A type, influenza B virus rapid typing detection reagent box and its application | |
Ashmi et al. | Molecular characterization of canine distemper virus from Tamil Nadu, India | |
Mojsiejczuk et al. | Molecular epidemiology of hepatitis B virus in Misiones, Argentina | |
CN106939355A (en) | A kind of screening of influenza virus attenuated live vaccines strain and authentication method | |
Gagliardi et al. | Human bocavirus respiratory infections in children | |
CN116479189A (en) | Whole-gene capturing method, primer combination and kit for syncytial virus subtype B | |
CN106854682A (en) | A kind of method that parting is carried out using gene infected by influenza | |
Venegas et al. | Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile | |
CN103614345A (en) | Influenza virus vaccine strain | |
CN103614495B (en) | Joint detection kit for influenza viruses A and B and application thereof | |
Atmar et al. | Typing and subtyping clinical isolates of influenza virus using reverse transcription-polymerase chain reaction | |
Yan et al. | CRF01_AE/B/C, a novel drug-resistant HIV-1 recombinant in men who have sex with men in Beijing, China | |
Mahmood et al. | Analysis of complete and partial genome sequences of hepatitis B virus and determination of its genotypes and sub-genotypes from Pakistan | |
Hijikata et al. | Genotyping of hepatitis E virus from Vietnam | |
Zhen et al. | Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese | |
CN101857872A (en) | Replacement method of influenza A Virus antigenic determinant | |
Soltanialvar et al. | Genetic analysis of polymerase complex (PA, PB1 and PB2) genes of H9N2 avian influenza viruses from Iran (1999 to 2009) | |
Kareem et al. | Hepatitis C Virus Genotyping In Sulaimani Governorate | |
WO2019129254A1 (en) | New use of influenza virus antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170616 |